Office of health affairs dissolves
This article was originally published in The Gray Sheet
Executive Summary
Professional staff members from the FDA Center for Devices and Radiological Health's office of health affairs are reassigned to positions in the office of standards and regulations and the office of device evaluation following the dissolution of OHA. OHA Deputy director Thomas Arrowsmith-Lowe, MD, and staffers Peter Paras and Robert Gottesman have moved to OSR. Four staffers have moved to ODE: Kevin Mulry, DDS, to the division of general and restorative devices; Claudia Gaffey, MD, to the division of clinical laboratory devices; and Mariana Kastrinakis, MD, and Suzanne Parisian, MD, to the division of reproductive, abdominal, ENT and radiological devices. OHA Director Gordon Johnson, MD, has retired.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.